BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 22447977)

  • 1. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
    Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
    J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different NK cell developmental events require different levels of IL-15 trans-presentation.
    Lee GA; Liou YH; Wang SW; Ko KL; Jiang ST; Liao NS
    J Immunol; 2011 Aug; 187(3):1212-21. PubMed ID: 21715685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No requirement of trans presentations of IL-15 for human CD8 T cell proliferation.
    Ota N; Takase M; Uchiyama H; Olsen SK; Kanagawa O
    J Immunol; 2010 Nov; 185(10):6041-8. PubMed ID: 20926799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
    Wu Z; Xu Y
    J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
    Votavova P; Tomala J; Kovar M
    Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced 2,4-dinitro-1-fluorobenzene-induced contact hypersensitivity response in IL-15 receptor alpha-deficient mice correlates with diminished CCL5/RANTES and CXCL10/IP-10 expression.
    Chen JP; Liao NS; Lai SL; Hsu L; Mao WY; Ku MC; Liao F
    Eur J Immunol; 2005 Mar; 35(3):690-8. PubMed ID: 15719370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.
    Rowley J; Monie A; Hung CF; Wu TC
    J Immunol; 2008 Dec; 181(12):8237-47. PubMed ID: 19050240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular common gamma chain confers B- and T-cell-independent protection against glomerulonephritis.
    Luque Y; Cathelin D; Vandermeersch S; Xu X; Sohier J; Placier S; Xu-Dubois YC; Louis K; Hertig A; Bories JC; Vasseur F; Campagne F; Di Santo JP; Vosshenrich C; Rondeau E; Mesnard L
    Kidney Int; 2017 May; 91(5):1146-1158. PubMed ID: 28111009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.
    Morandi B; Mortara L; Carrega P; Cantoni C; Costa G; Accolla RS; Mingari MC; Ferrini S; Moretta L; Ferlazzo G
    Int Immunol; 2009 May; 21(5):599-606. PubMed ID: 19325034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-15 has innate anti-tumor activity independent of NK and CD8 T cells.
    Davies E; Reid S; Medina MF; Lichty B; Ashkar AA
    J Leukoc Biol; 2010 Sep; 88(3):529-36. PubMed ID: 20538758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin induces dendritic cell activation via PLCγ/JNK/NF-κB pathways, leading to Th1 and Th17 polarization.
    Jung MY; Kim HS; Hong HJ; Youn BS; Kim TS
    J Immunol; 2012 Mar; 188(6):2592-601. PubMed ID: 22345647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets.
    Mortier E; Advincula R; Kim L; Chmura S; Barrera J; Reizis B; Malynn BA; Ma A
    Immunity; 2009 Nov; 31(5):811-22. PubMed ID: 19913445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells.
    Tamzalit F; Barbieux I; Plet A; Heim J; Nedellec S; Morisseau S; Jacques Y; Mortier E
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8565-70. PubMed ID: 24912180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.
    Hansen ML; Woetmann A; Krejsgaard T; Kopp KL; Søkilde R; Litman T; Straten PT; Geisler C; Wasik MA; Odum N; Eriksen KW
    Mol Immunol; 2011 Sep; 48(15-16):2087-93. PubMed ID: 21813181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting Edge: Differential Fine-Tuning of IL-2- and IL-15-Dependent Functions by Targeting Their Common IL-2/15Rβ/γc Receptor.
    Meghnem D; Morisseau S; Frutoso M; Trillet K; Maillasson M; Barbieux I; Khaddage S; Leray I; Hildinger M; Quéméner A; Jacques Y; Mortier E
    J Immunol; 2017 Jun; 198(12):4563-4568. PubMed ID: 28507024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.
    Dorner BG; Scheffold A; Rolph MS; Huser MB; Kaufmann SH; Radbruch A; Flesch IE; Kroczek RA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6181-6. PubMed ID: 11972057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
    Gill N; Rosenthal KL; Ashkar AA
    J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of NF-κB, ERK1/2 and AP-1 in modulating the immunoregulatory functions of bone marrow-derived dendritic cells from NOD mice.
    Guindi C; Ménard M; Cloutier A; Gaudreau S; Besin G; Larivée P; McDonald PP; Dupuis G; Amrani A
    Cell Immunol; 2012; 272(2):259-68. PubMed ID: 22070873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
    Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.